Aquestive Therapeutics, Inc. Common Stock AQST
HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERICi
Market dataready · fetched 2026-11-11T14:40:39.444Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T14:40:32.099312559Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-11T14:38:28.418327+00:00
Aquestive Therapeutics, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | 3.00 | 219.9% | 22.3% | |||
| 30Δ | 3.08 | 207.1% | 20.5% | |||
| 35Δ | 3.44 | 155.5% | 11.1% | 3.16 | 194.3% | 18.7% |
| 40Δ | 3.25 | 181.7% | 10.3% | 3.25 | 181.5% | 16.9% |
| 45Δ | 3.05 | 208.0% | 9.5% | 3.33 | 168.6% | 15.2% |
| 50Δ | 2.86 | 234.3% | 8.7% | 3.41 | 155.8% | 13.4% |
| 55Δ | 2.67 | 260.5% | 7.8% | 3.49 | 143.0% | 11.6% |
| 60Δ | 2.47 | 286.8% | 7.0% | 3.57 | 130.2% | 9.8% |
| 65Δ | 2.28 | 313.1% | 6.2% | 3.65 | 117.4% | 8.1% |
| 70Δ | 2.08 | 339.4% | 5.4% | |||
| 75Δ | 1.89 | 365.6% | 4.6% | |||
| 80Δ | 1.70 | 391.9% | 3.8% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 3.00
- IV
- 219.9%
- B/E move
- 22.3%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 3.08
- IV
- 207.1%
- B/E move
- 20.5%
35Δ
- Pseudo strike
- 3.44
- IV
- 155.5%
- B/E move
- 11.1%
- Pseudo strike
- 3.16
- IV
- 194.3%
- B/E move
- 18.7%
40Δ
- Pseudo strike
- 3.25
- IV
- 181.7%
- B/E move
- 10.3%
- Pseudo strike
- 3.25
- IV
- 181.5%
- B/E move
- 16.9%
45Δ
- Pseudo strike
- 3.05
- IV
- 208.0%
- B/E move
- 9.5%
- Pseudo strike
- 3.33
- IV
- 168.6%
- B/E move
- 15.2%
50Δ
- Pseudo strike
- 2.86
- IV
- 234.3%
- B/E move
- 8.7%
- Pseudo strike
- 3.41
- IV
- 155.8%
- B/E move
- 13.4%
55Δ
- Pseudo strike
- 2.67
- IV
- 260.5%
- B/E move
- 7.8%
- Pseudo strike
- 3.49
- IV
- 143.0%
- B/E move
- 11.6%
60Δ
- Pseudo strike
- 2.47
- IV
- 286.8%
- B/E move
- 7.0%
- Pseudo strike
- 3.57
- IV
- 130.2%
- B/E move
- 9.8%
65Δ
- Pseudo strike
- 2.28
- IV
- 313.1%
- B/E move
- 6.2%
- Pseudo strike
- 3.65
- IV
- 117.4%
- B/E move
- 8.1%
70Δ
- Pseudo strike
- 2.08
- IV
- 339.4%
- B/E move
- 5.4%
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- 1.89
- IV
- 365.6%
- B/E move
- 4.6%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 1.70
- IV
- 391.9%
- B/E move
- 3.8%
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 80.95% | |
| 67.00% | |
| 77.85% | |
| 76.00% | |
| 81.15% | |
| 71.36% | |
| 79.52% | |
| 111.50% | |
| 108.51% | |
| 79.50% | |
| 86.06% | |
| 101.52% | |
| 82.49% | |
| 82.99% | |
| 95.81% | |
| 143.96% | |
| 120.82% | |
| 73.51% | |
| 114.16% | |
| 104.44% | |
| 100.05% | |
| 123.79% | |
| 106.58% |
Drug Manufacturers - Specialty & Generic
BCRX
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small molecule drugs. The company is headquartered in Durham, North Carolina.
More →BHC
Bausch Health Companies Inc. develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter (OTC) products primarily in the therapeutic areas of…
More →BIOA
Description unavailable
More →CGC
Canopy Growth Corporation is engaged in the production, distribution and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the…
More →COLL
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and markets pain management medications. The company is headquartered in Stoughton, Massachusetts.
More →CPIX
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and marketing of prescription products for hospital acute care,…
More →